Notes
Amendment
25 Nov 2022 -
Supplementary data table 4 diagnosis (Table S17.1): corrected age-standardised rates for 25–74 for 2018, 2019, and 2020.
National Cervical Screening Program monitoring report 2021
Publication
Release Date:
Topic: Cancer screening
Citation
AIHW
Australian Institute of Health and Welfare (2021) National Cervical Screening Program monitoring report 2021, AIHW, Australian Government, accessed 27 April 2024. doi:10.25816/mz9j-9925
APA
Australian Institute of Health and Welfare. (2021). National Cervical Screening Program monitoring report 2021. Canberra: AIHW. doi:10.25816/mz9j-9925
MLA
Australian Institute of Health and Welfare. National Cervical Screening Program monitoring report 2021. AIHW, 2021. doi:10.25816/mz9j-9925
Vancouver
Australian Institute of Health and Welfare. National Cervical Screening Program monitoring report 2021. Canberra: AIHW; 2021. doi:10.25816/mz9j-9925
Harvard
Australian Institute of Health and Welfare 2021, National Cervical Screening Program monitoring report 2021, AIHW, Canberra. doi:10.25816/mz9j-9925
PDF | 1.6Mb
Newer release available
This is the third report to monitor the National Cervical Screening Program since it introduced 5-yearly HPV tests in December 2017. In 2018–2020, there were more than 3.8 million participants aged 25–74, and in 2020, 10% of all screening HPV tests performed were positive for HPV types that cause cervical cancer. Cervical cancer incidence and mortality remained low at 10 new cases and 2 deaths per 100,000 women, respectively.
- ISSN: 2651-9623
- ISBN: 978-1-76054-943-5
- DOI: 10.25816/mz9j-9925
- Cat. no: CAN 141
- Pages: 140
Findings from this report:
-
More than 3.8 million cervical screening participants aged 25–74 in 2018–2020
-
179 women aged 25–74 died from cervical cancer in 2019
-
743 women aged 25–74 diagnosed with cervical cancer in 2017
-
Cervical screening test positivity 10% in 2020